Distillate U.S. Fundamental Stability & Value ETF (DSTL) is an actively managed exchange-traded fund that seeks to achieve long-term capital appreciation by investing in a portfolio of approximately 100 large-cap U.S. stocks selected for their low debt levels, stable cash flows, and attractive valuations based on Distillate Capital Partners LLC's proprietary normalized free cash flow methodology; the portfolio is weighted by free cash flow generation and rebalanced quarterly. DSTL begins with a universe of around 500 profitable large-cap U.S. stocks, focusing on those exhibiting fundamental stability and value characteristics across diversified sectors including healthcare, technology, industrials, and consumer staples, with top holdings such as Johnson & Johnson, AbbVie Inc., and Merck & Co. Inc. The ETF, with net assets exceeding $1.7 billion as of late 2025, trades on the NYSE Arca exchange and distributes quarterly dividend income.
Launched on October 23, 2018, by Distillate Capital Partners LLC, a Chicago-based investment adviser founded in 2017 and headquartered at 401 North Michigan Avenue, the fund operates exclusively within the U.S. equity market, targeting institutional and retail investors seeking a blend of value and quality factors. Distillate Capital Partners, which is 100% employee-owned and manages over $2 billion across strategies including DSTL, DSTX, and DSMC, emphasizes free cash flow over traditional metrics in an asset-light economy.
In recent developments, DSTL has sustained robust asset growth amid favorable market conditions, with net assets reaching $1,795,965,514 and shares outstanding at 31.4 million by November 2025, alongside continued quarterly distributions such as $0.183 per share in September 2025. Distillate Capital issued its Q3 2025 letter highlighting the strategy's valuation advantages relative to benchmarks like the Russell 1000 Value Index and equal-weight S&P 500, while demonstrating portfolio resilience through systematic rebalancing and holdings adjustments, including additions like Enterprise Products Partners LP in September 2025. The firm received third-party recognition in U.S. News & World Report's "7 Best Stock Fund Managers" on March 25, 2025, underscoring its performance track record since inception.